2026 Influenza Vaccine Checker

• 2026 uses TIV only (3 strains) in Australia.
• Funding: NIP for all children 6 months to <5 years, plus First Nations people, pregnancy, and eligible medical conditions. Others are private unless otherwise covered by local programs.
• Dosing: children aged 6 months to <2 years in their first vaccination year need 2 doses at least 4 weeks apart. Children aged 2 to <5 years need 1 funded dose. Children under 9 with a medical risk condition receiving influenza vaccine for the first time are funded for 2 doses.
• Co‑admin: can be given with COVID‑19 vaccines; in pregnancy it can also be given with pertussis (20–32 weeks) and RSV vaccine (28–36 weeks).
• Egg allergy: not a contraindication. Latex: NIP 2026 influenza vaccines are latex‑free.

• Funding: ages 5–64 with eligible medical conditions.
• Preference: no preferential recommendation versus standard dose egg‑based influenza vaccines.
• Co‑admin: can be given with COVID‑19 vaccines.

• Preferentially recommended for adults ≥65 years on the NIP.
• Private market note: Fluzone High‑Dose is also preferentially recommended, but it is not NIP funded.
• Co‑admin: can be given with COVID‑19, RSV and shingles vaccines.

• Children 6 months to <5 years.
• Pregnant women — any stage, every pregnancy.
• Aboriginal and Torres Strait Islander people aged ≥6 months.
• People aged ≥65 years (adjuvanted TIV recommended on the NIP).
• People aged ≥6 months with certain medical conditions including cardiac disease, chronic respiratory conditions, immunocompromising conditions, haematological disorders, chronic metabolic disorders, chronic kidney disease, chronic neurological conditions, and long‑term aspirin therapy in children 5–10 years.

Vaccination is recommended when the 2026 vaccine becomes available in April 2026 and should continue while influenza is circulating and a valid vaccine is available.

• FluMist® Spray is for ages 2–17 years only.
• It is available through state‑based immunisation programs in New South Wales, Queensland, South Australia and Western Australia.
• In Victoria, Tasmania, the ACT and the NT, supply for ages 2–17 years requires a private prescription.
• Pregnancy and moderate/severe immunocompromise: use inactivated influenza vaccines rather than LAIV.
• This box highlights when an age between 2 and 17 years is selected.